Compared to DPP4 inhibitor, GLP-1RA use was associated with decreased risks of 30 outcomes, including respiratory failure, pneumonia, anemia, post-thrombotic sequelae, and bacterial infections, and increased risk of 13 outcomes, including sleep disturbances, nausea, vomiting, headaches, hypotension, sleep disturbances, and nephrolithiasis
Whether choosing Mochi, compounded GLP-1, or another telehealth model, consider asking your provider whether genetic or metabolic assessment would enhance your individual treatment plan
The effectiveness of Ozempic is based on consistent weekly use, not the time of day
While most insurers cover GLP-1s like Rybelsus for type 2 diabetes, its generally not covered if prescribed for an off-label use like weight loss
Vitamin B-12-fortified toothpaste improves vitamin status in vegans: a 12-wk randomized placebo-controlled study
While diarrhea affects many Ozempic patients, especially during the initial weeks of treatment, understanding its causes and management strategies may help make the experience more bearable